Improvement of schizophrenia negative and positive symptoms with amantadine as add-on therapy to antipsychotics: A case series

Revista Brasileira de Psiquiatria

Volumn 32, Issue 2, 2010, Pages 193-195

  Gama, Clarissa Severino ^a   De Lucena, David ^a   Cruz, Cíntia ^a   Lobato, Maria Inês ^a   Belmonte de Abreu, Paulo Silva ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CITALOPRAM; CLOZAPINE; DIAZEPAM; GLUTAMIC ACID; HALOPERIDOL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; BRIEF PSYCHIATRIC RATING SCALE; CASE REPORT; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; TREATMENT DURATION; TREATMENT RESPONSE;

AMANTADINE; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NOOTROPIC AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 77958476407     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462010000200017     Document Type: Letter

References (5)

1. Bressan RA, Pilowsky LS. Glutamatergic hypothesis of schizophrenia. Rev Bras Psiquiatr. 2003;25(3):177-83.
2. de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, GAMA CS. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. J Clin Psychiatry. 2009;70(10):1416-23.
3. Peeters M, Page G, Maloteaux JM, Hermans E. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine. Brain Res. 2002;949(1-2):32-41. (Pubitemid 35246174)
4. Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci. 2001;18(3):247-58. (Pubitemid 33027930)
5. Gama CS, Berk M, Andreazza AC, Kapczinski F, Belmonte-de-Abreu P. Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation. Rev Bras Psiquiatr. 2008;30(4):337-40.